Business Description
![Madrigal Pharmaceuticals Inc Madrigal Pharmaceuticals Inc logo](https://static.gurufocus.com/logos/0C00000PDU.png?14)
Madrigal Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US5588681057
Description
Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 9 | |||||
Equity-to-Asset | 0.79 | |||||
Debt-to-Equity | 0.14 | |||||
Debt-to-EBITDA | -0.27 | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -13 | |||||
3-Year EPS without NRI Growth Rate | -15.2 | |||||
3-Year FCF Growth Rate | -19.5 | |||||
3-Year Book Growth Rate | 9.6 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 62.73 | |||||
9-Day RSI | 66.11 | |||||
14-Day RSI | 64.55 | |||||
6-1 Month Momentum % | -5.99 | |||||
12-1 Month Momentum % | -21.48 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 9.39 | |||||
Quick Ratio | 9.39 | |||||
Cash Ratio | 9.26 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -8.6 | |||||
Shareholder Yield % | -10.58 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -145 | |||||
ROA % | -85.58 | |||||
ROIC % | -2861.19 | |||||
ROC (Joel Greenblatt) % | -19337.28 | |||||
ROCE % | -104.13 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 6.75 | |||||
Price-to-Tangible-Book | 6.79 | |||||
EV-to-EBIT | -11.57 | |||||
EV-to-Forward-EBIT | -7.54 | |||||
EV-to-EBITDA | -11.58 | |||||
EV-to-Forward-EBITDA | -7.56 | |||||
EV-to-Forward-Revenue | 62.56 | |||||
EV-to-FCF | -12.72 | |||||
Price-to-Net-Current-Asset-Value | 6.81 | |||||
Price-to-Net-Cash | 6.94 | |||||
Earnings Yield (Greenblatt) % | -8.64 | |||||
FCF Yield % | -6.61 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Madrigal Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -21.368 | ||
Beta | 1.34 | ||
Volatility % | 73 | ||
14-Day RSI | 64.55 | ||
14-Day ATR (€) | 8.35947 | ||
20-Day SMA (€) | 222.43 | ||
12-1 Month Momentum % | -21.48 | ||
52-Week Range (€) | 113.8 - 295 | ||
Shares Outstanding (Mil) | 21.31 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Madrigal Pharmaceuticals Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Madrigal Pharmaceuticals Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Madrigal Pharmaceuticals Inc Frequently Asked Questions
What is Madrigal Pharmaceuticals Inc(STU:YDO1)'s stock price today?
The current price of STU:YDO1 is €251.20. The 52 week high of STU:YDO1 is €295.00 and 52 week low is €113.80.
When is next earnings date of Madrigal Pharmaceuticals Inc(STU:YDO1)?
The next earnings date of Madrigal Pharmaceuticals Inc(STU:YDO1) is 2024-08-08 Est..
Does Madrigal Pharmaceuticals Inc(STU:YDO1) pay dividends? If so, how much?
Madrigal Pharmaceuticals Inc(STU:YDO1) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |